Centre allocates additional 19,420 vials of Amphotericin-B to States, UTs

In view of the rising black fungus cases, the Ministry of Chemicals and Fertilizers on Tuesday informed that it has allocated 19,420 additional vials of Amphotericin-B to various States and UTs

Injection for Black Fungus
ANI General News
2 min read Last Updated : May 25 2021 | 11:58 AM IST

In view of the rising Mucormycosis (commonly known as black fungus) cases across the country, the Ministry of Chemicals and Fertilizers on Tuesday informed that it has allocated 19,420 additional vials of Amphotericin-B to various States and Union Territories.

"Additional 19,420 vials of #Amphotericin-B have been allocated to all States/UTs and Central Institutions today. Besides this, 23680 vials of Amphotericin- B were allocated across country on 21st May", tweeted the Union Minister for Chemicals and Fertilizers, DV Sadananda Gowda.

Mucormycosis or black fungus is a fungal infection caused by exposure to mucor mould which is commonly found in soil, plants, manure, and decaying fruits and vegetables.

As of now, Amphotericin-B, an anti-fungal drug is being used for the treatment of the black fungus disease.

The Union Health Ministry, on May 20, urged the states to make mucormycosis, a notifiable disease under the Epidemic Diseases Act 1897. The central government has made it mandatory for states to report both suspected and confirmed cases of mucormycosis to the Integrated Disease Surveillance Programme (IDSP).

Cases of black fungus infection are being reported in several parts of the country. States like Rajasthan, Gujarat, Punjab, Haryana, Karnataka, Odisha, Telangana and Tamil Nadu have already declared it a 'notifiable' disease under the Epidemic Diseases Act, thereby making it mandatory to report every Mucormycosis case to the state government.

Delhi also reported more than 500 cases of black fungus till yesterday, as per Chief Minister Arvind Kejriwal.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCorona Remediescorona

First Published: May 25 2021 | 11:50 AM IST

Next Story